AMINA JAWAID: Open Payments
NPI 1942908892 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,343 in 58 payments from 6 companies in 2025. Trend: 2023 $929 · 2024 $1,207 · 2025 $1,343
Food & beverage: $1,343
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 14 | $492 |
| Gilead Sciences, Inc. | 21 | $365 |
| Intercept Pharmaceuticals, Inc. | 10 | $244 |
| Ipsen Biopharmaceuticals, Inc | 9 | $158 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
Products named: REZDIFFRA, OCALIVA, IQIRVO, XIFAXAN, LIVTENCITY.
Industry payments across OK — which companies pay providers there.
